Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Journal for ImmunoTherapy of Cancer

Fig. 2

From: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

Fig. 2

Whisker plots (Tukey) of CD8+ (a, c, e, g) and CD163+ (i, k, m, o) counts in the tumor center (TC) and CD8+ (b, d, f, h) and CD163+ (j, l, n, p) counts in the invasive margin (IM) according to clinicopathological variables: Grade (a, b, i, j), T status (c, d, k, l), LN status (e, f, m, n) and TNM stage (g, h, o, p). G = grade; T = tumor size; LN = lymph node; TNM stage: early = I&IIA and advanced = IIB&III

Back to article page